Natco Pharma Q3 net down 34.5% at ₹104 crore

Our Bureau Hyderabad | Updated on February 12, 2020

Natco Pharma Ltd’s consolidated net profit declined 34.5 per cent at ₹104 crore in the third quarter ended December 31, 2019 compared to ₹159 crore in the same period last year.

The total revenue of the company also decreased to ₹513 crore from ₹580 crore in the corresponding quarter of previous financial year. “The company continues to face margin pressure,’’ Natco said in a release issued here on Wednesday.

The board of directors has recommended a third interim dividend of ₹3.50 per equity share of ₹2 each.

Published on February 12, 2020

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like